Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00065689 · ClinicalTrials.gov registry record · Phase 3
High Intensity Light Therapy in Alzheimer's Disease
A Phase 3 study of Dementia and Alzheimers Disease, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 3
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT00065689 is a Phase 3 study of Dementia and Alzheimers Disease that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 107 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00065689, a Phase 3 study of Dementia and Alzheimers Disease, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether bright light improves the sleep, mood, and behavior of persons with Alzheimer's disease and related dementias (AD) who live in long-term care settings and, if so, to determine the best timing for the light therapy. The light levels being used in the study have been shown to improve depression in persons with seasonal affective disorder (SAD) and to relieve sleep problems in persons with jet lag and other body rhythm disturbances. Because persons with AD often will not remain still in front of a fluorescent panel, this project has involved renovations in the study units that provide for even, regulated, high-intensity light in all public areas of the study settings.
Conditions Studied
Interventions
- DEVICE high-intensity light therapy
Study Locations (1)
North Carolina
- John Umstead Hospital - Butner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2003-03 |
| Est. Completion | 2005-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00065689
The ClinicalTrials.gov registry entry for NCT00065689 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which high-intensity light therapy is the first listed.
NCT00065689 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00065689 about?
NCT00065689 is a clinical study titled "High Intensity Light Therapy in Alzheimer's Disease". The purpose of this study is to determine whether bright light improves the sleep, mood, and behavior of persons with Alzheimer's disease and related dementias (AD) who live in long-term care settings and, if so, to determine the best timing for the light therapy. The light levels being used in the ...
What is the current status of trial NCT00065689?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 107 participants. The study started on 2003-03. Estimated completion is 2005-09.
What conditions does trial NCT00065689 study?
This clinical trial studies the following conditions: Dementia, Alzheimers Disease.
What interventions are being tested in trial NCT00065689?
The interventions under investigation include: high-intensity light therapy (DEVICE).
Who is sponsoring clinical trial NCT00065689?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00065689 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ACHIEVE Brain Health Follow-Up Study
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
ACTIVE NOT RECRUITING · Phase 3
-
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease
ACTIVE NOT RECRUITING · Phase 3
-
Escitalopram for Agitation in Alzheimer's Disease
ACTIVE NOT RECRUITING · Phase 3
-
Preventing Cognitive Decline With Alternative Therapies
COMPLETED · Phase 3
-
Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.